feed,title,long_url,short_url
gNews,Novo Nordisk shares fall 7% after Eli Lilly obesity drug trial results; European markets move lower - CNBC,https://news.google.com/rss/articles/CBMilgFBVV95cUxPY0RPdTRDeDVUX2Y5emtMbktlYi03cE1VZ3VnRFlCc3pzY2xhZWpzdmtDVEJCWXJXQVNRVFNscGJWZTZ4VkJhT1RFb3h2R29WWFR5dm5FVlFTOHN3dmYzYXJlSTRoRXFEdkt4OHU1MTA3STltVERuTnNiWkJRSXduYkRjVElld1d3cXVFNTdoYkpyaHBvWlHSAZsBQVVfeXFMTTVoNk11c3FMQzhZNmJ6cTN1eGF0Y1lJQmJ0V2txOF9jcDUzdFBicWFvSF95MzlEMWh4MU1SZGFNM2pzOXc5UWxoa0RNRk11RGtmMG1XLXM3RllfOE1QeGR6VlY1NWtUUmp4cjc0T2dHNk1ZNFFweno3STRSQURMajBQUFgwYjZ5NlNKQmxBalhlWUpXSmhkazdhNkk?oc=5,https://da.gd/WfQV5
